reviewDiabetologiaJan 26, 2012BRONZE OA

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

GMGiovanni MussoMCMaurizio CassaderFRF. RosinaRGRoberto Gambino

Ospedale Regina Margherita · Ospedale Humanitas Gradenigo · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

666
total citations
FWCI
33.16
Percentile
100%
References
141
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Fatty liver
  • Medicine
  • Steatohepatitis
  • Pioglitazone
  • Internal medicine
  • Steatosis
  • Insulin resistance
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding